Keywords: Astellas, Theravance, Vibativ, Canada approval

Health Canada clears Astellas/Theravance’s Vibativ for cSSSI indications

Article | 02 October 2009

Print This

Drug industry regulator Health Canada has approved Astellas Pharma Canada, a unit of the like-named Japanese drug major, and Theravance’ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in